California-based Demetrix secured $50 million in a Series A funding, which the company will use for research of synthetic cannabinoid production.
Nick Thomas
Nick Thomas's Latest Posts
Biosynthesis: The Next Cannabis Market Disruptor?
Biosynthesis – the mass production of specific cannabinoids in a lab setting – might be setting up to be the next big disruptor for the cannabis industry.
In cannabis, the process, also known as cellular agriculture, is increasingly being used to produce THC, CBD and other cannabinoids – with results that can boast greater than 99% purity – in less time and at a lower cost than plant-based production.
Marijuana company KushCo reports higher revenues, wider losses
KushCo Holdings, a California-based provider of ancillary products and services for the cannabis industry, on Tuesday reported revenues of $41.5 million for its fiscal third quarter, a 221.5% jump from $12.9 million in the same period a year ago.
Surterra taps new CFO from Kellogg, continuing cannabis hiring trend
Surterra Wellness, a fast-growing marijuana company based in Atlanta, on Tuesday announced it hired a highly paid executive from the Kellogg Co. as chief financial officer. Fareed Khan, the latest Kellogg exec to leave the Fortune 500 company...
Green Growth acquires multistate marijuana firm Moxie in $310 million deal
Green Growth Brands, a cannabis company based in Ohio, agreed to pay $310 million in stock for multistate operator Moxie.
Canadian marijuana firm Sundial, California’s KushCo seek Nasdaq listings
Sundial Growers, a Canadian cannabis company, and California-based KushCo Holdings have applied to be listed on the Nasdaq.
Sol Global cannabis investment firm raises CA$50 million; exec resigns
Sol Global, a Toronto-based international cannabis investment firm, said it raised 50 million Canadian dollars ($37.5 million) in debt financing. The company will use the proceeds to fund its expansion in CBD activities and operations in California, Florida and...
Linton’s firing by Canopy follows string of losses, may raise concerns about cannabis sector-mainstream partnerships
Former Canopy Growth co-CEO Bruce Linton may have had suspicions about his future when a special board meeting of the Canadian cannabis giant was convened last Friday. Even though Linton was also Canopy's chair, he didn't call the meeting. By Wednesday, Linton was...
Cannabis company Surterra closes $100 million funding, adds executives
Surterra Wellness, an Atlanta-based medical cannabis company, closed a $100 million share offering whose net proceeds will be used to fund acquisitions and capital expenditure. The company also said it is taking on two new directors to help...
Marijuana firm High Times explores OTC, not Nasdaq, as it falls short of capital target
High Times Holding Corp., the parent company of the iconic High Times cannabis magazine, fell well short of its $50 million equity raise target and will aim for a listing on the OTC markets as opposed to the Nasdaq. Here's what you need to know:[include_post...
Canopy Growth reports increased marijuana revenue, mounting losses
Ontario, Canada-based marijuana firm Canopy Growth reported net revenue of 94.1 million Canadian dollars ($71.5 million) for the fiscal fourth quarter ended March 31, up from CA$22.8 million in the same period a year ago.
Cannabis company Vireo Health expands into Puerto Rico
Vireo Health, a Minneapolis-based multistate marijuana operator, said it is expanding into Puerto Rico, the company's 11th state or territory of cannabis operations. Vireo will have the opportunity in Puerto Rico to run a cultivation and processing facility plus up to...
